Please assess the completion status of the following clinical trial:

Trial Title: The Fibrin Patch Soft Tissue Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects \>= 18 years of age, requiring non-emergent, open, abdominal, retroperitoneal, pelvic or thoracic (non-cardiac) surgical procedures~* Presence of an appropriate soft tissue Target Bleeding Site (TBS) as identified intraoperatively by the surgeon~* Subjects must be willing to participate in the study, and provide written informed consent~Exclusion Criteria:~* Subjects with any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure~* Subject with TBS within an actively infected field~* Bleeding site is in, around, or in proximity to foramina in bone, or areas of bony confine~* Subjects with known intolerance to blood products or to one of the components of the study product~* Subjects unwilling to receive blood products~* Subjects with immunodeficiency diseases (including known HIV)~* Subjects who are known, current alcohol and / or drug abusers~* Subjects who have participated in another investigational drug or device research study within 30 days of enrollment~* Female subjects who are pregnant or nursing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): SURGICEL™ Absorbable Hemostat

Based on this trial design, predict the completion outcome and termination type (if applicable).